당뇨병 치료 기기 및 치료제 시장 : 시장 규모, 점유율, 성장 분석 - 유형별, 유통 경로별, 최종 용도별, 지역별 업계 예측(2026-2033년)

Diabetes Care Devices and Drugs Market size was valued at USD 32.56 Billion in 2024 and is poised to grow from USD 35.13 Billion in 2025 to USD 64.55 Billion by 2033, growing at a CAGR of 7.9% during the forecast period (2026-2033).

Diabetes remains a critical global health challenge, characterized by inadequate insulin production leading to elevated blood glucose levels. Continuous glucose monitors, pivotal in diabetes management, enable patients to track their glucose levels effortlessly throughout the day. With millions affected worldwide, diabetes poses significant risks, including complications such as kidney failure and cardiovascular events. The prevalence is particularly prominent in low- and middle-income nations, attributed to rising obesity rates, sedentary lifestyles, and limited awareness. The upward trend in newly diagnosed type 1 and type 2 diabetes cases is projected to sustain demand for diabetes care devices. This demand is further fueled by the increasing adoption of insulin delivery systems and manufacturers' commitment to innovation, enhancing treatment options and improving patient outcomes in diabetes management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Diabetes Care Devices and Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Diabetes Care Devices and Drugs Market Segments Analysis

Global Diabetes Care Devices and Drugs Market is segmented by Type, Distribution Channel, End-use and region. Based on Type, the market is segmented into BGM Devices and Insulin Delivery Devices. Based on Distribution Channel, the market is segmented into Hospital pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies and Others. Based on End-use, the market is segmented into Hospitals, Diagnostic Centers and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Diabetes Care Devices and Drugs Market

The growth of the diabetes care devices and drugs market is significantly influenced by the continuous introduction of innovative products aimed at improving diabetes management. Advancements in diabetes monitoring systems and treatment devices contribute to this expansion, as evidenced by ongoing research initiatives exploring methods like coating insulin-loaded nanoparticles to enhance oral insulin delivery. Furthermore, heightened investments in research and development, alongside collaborative efforts among various stakeholders, are expected to foster additional opportunities for market growth. This dynamic environment encourages the creation of advanced solutions, ultimately improving patient outcomes and driving market demand.

Restraints in the Diabetes Care Devices and Drugs Market

The growth of the diabetes care devices and drugs market may be hindered by various factors, including inadequate reimbursement policies and strict regulations in certain regions. Additionally, the increasing prevalence of obesity, which is closely linked to diabetes, poses challenges for market expansion. Moreover, a significant lack of awareness regarding diabetes diagnosis and treatment options, particularly in developing countries, further obstructs the potential advancement of this market. These combined issues create substantial obstacles that could impede the overall progress and development of diabetes care solutions across the globe.

Market Trends of the Diabetes Care Devices and Drugs Market

The Diabetes Care Devices and Drugs market is experiencing a positive trajectory driven by heightened awareness and concern about managing diabetes, particularly in the context of health challenges like the coronavirus. As individuals with diabetes are recognized as being at increased risk, there has been a substantial surge in demand for monitoring devices and therapeutic solutions that facilitate at-home management. This trend reflects a growing preference for remote healthcare solutions, enhancing patient autonomy and adherence to treatment regimens. Additionally, innovations in technology and personalized medicine continue to fuel advancements, creating a dynamic and evolving market landscape focused on improved patient outcomes and quality of life.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Diabetes Care Devices and Drugs Market Size by Type & CAGR (2026-2033)

• Market Overview
• BGM Devices
  • Self-Monitoring Devices
  • Blood Glucose Meters
  • Testing Strips
  • Lancets
  • Continuous Glucose Monitoring Devices
  • Sensors
  • Transmitters
  • Receiver
• Insulin Delivery Devices
  • Pumps
  • Pens
  • Syringes and Needles
  • Jet Injectors

Global Diabetes Care Devices and Drugs Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital pharmacies
• Retail Pharmacies
• Diabetes Clinics/Centers
• Online Pharmacies
• Others

Global Diabetes Care Devices and Drugs Market Size by End-use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Centers
• Homecare

Global Diabetes Care Devices and Drugs Market Size & CAGR (2026-2033)

• North America (Type, Distribution Channel, End-use)
  • US
  • Canada
• Europe (Type, Distribution Channel, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Distribution Channel, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Distribution Channel, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Distribution Channel, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations